AC
VRTX icon

Amia Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Amia Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,026
Closed -$1.37M – 27
2020
Q3 		$1.37M Sell
5,026
-2,325
-32% -$641K 1.59% 10
2020
Q2 		$2.13M Sell
7,351
-3,458
-32% -$938K 1.75% 9
2020
Q1 		$2.57M Sell
10,809
-3,588
-25% -$823K 2.29% 8
2019
Q4 		$3.15M Buy
+14,397
New +$2.91M 0.92% 13

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Amia Capital's VRTX Position: Q4 2020 in Review

Amia Capital sold out of Vertex Pharmaceuticals (VRTX) in Q4 2020, closing a stake of 5,026 shares — an estimated $1.37M sold.

Amia Capital first reported a position in VRTX in Q4 2019 and held it in 4 quarters. The position peaked at $3.15M in Q4 2019. 970 funds tracked by Wall St. Rank hold VRTX as of Q4 2020.

  • Amia Capital reported no remaining Vertex Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Amia Capital sold 5,026 Vertex Pharmaceuticals shares in Q4 2020, an estimated $1.37M.
  • Amia Capital first reported a position in Vertex Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • Amia Capital's Vertex Pharmaceuticals position peaked at $3.15M in Q4 2019.
  • 970 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2020.

Based on Amia Capital's 13F filing for Q4 2020, filed 11 Feb 2021.